The Tissue Engineering-based Regeneration Products market
Roots Analysis has announced the addition of “Tissue Engineering-based Regeneration Products Market, 2022-2035” report to its list of offerings.
Given the ever-increasing demand for tissue transplantation, primarily for wound and , there is an urgent need for safe and efficient products that enable healing and regeneration. At present, the supply of tissue donations is insufficient to satisfy the required demand. It is worth highlighting that, in recent years, tissue engineering and have emerged as promising alternatives for tissue regeneration.
To request a sample copy / brochure of this report, please visit
Key Market Insights
Over 115 -based skin regeneration products are presently available in this market space
About 50% of the total products are intended for wound healing, followed by developed for the purpose of surgical healing. Further, more than 50% of the products are made of human placental tissues, followed by those developed using other animal-based tissues.
~40 tissue engineering-based bone regeneration products are being offered by developers, globally
About 55% of the total products are made from bone tissues, followed by those developed using stem cells. In fact, most of the products are formulated in the form of a sheet (10), followed by those developed in the form of a bone matrix. Further, nearly 75% of the products are available in the form of xenografts.
Around 60 players are engaged in the development of the tissue engineering-based regeneration products
Majority of the players engaged in this domain are mid-sized fir""
Author Signature :
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.